Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Randomized Study to Evaluate the Safety and the Humoral and Intestinal Immunogenicity of One or Two Additional Doses of Licensed Inactivated Polio Vaccines (IPVs) in Latin American Infants Previously Vaccinated With Bivalent Oral Polio Vaccines (bOPVs)

NCT01831050 is registered in ClinicalTrials.gov with Fidec Corporation as lead sponsor.

NCT NCT01831050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01831050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Randomized Study to Evaluate the Safety and the Humoral and Intestinal Immunogenicity of One or Two Additional Doses of Licensed Inactivated Polio Vaccines (IPVs) in Latin American Infants Previously Vaccinated With Bivalent Oral Polio Vaccines (bOPVs)
Lead sponsor
Fidec Corporation
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2013
Completion date
December 31, 2014
Enrollment
1,420 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

poliomyelitis